8th Annual Lung Cancer Symposium
The Lung Cancer Continuum: A Multidisciplinary Approach to Lung Cancer Care
Lung cancer remains the leading cause of cancer-related deaths in the United States, responsible for nearly one in five cancer fatalities. Enhancing early detection and expanding access to innovative treatment options has never been more critical.
Maimonides Health and its Department of Thoracic Surgery and Lung Cancer Screening Program are excited to provide a free, half-day symposium designed to educate and engage hospital-based and community providers to enhance their knowledge and clinical practice in the continuum of lung cancer care. From early detection to precision treatment, advancements in lung cancer care are enabling faster diagnosis and more effective therapies.
This hybrid (virtual and in person) symposium will showcase these innovations, emphasizing the lifesaving role of screening, and feature expert presentations, panel discussion, and case-based learning.
The Lung Cancer Continuum: A Multidisciplinary Approach to Lung Cancer Care
Date: Friday, October 30, 2026
Time: 7:00 am–2:00 pm
Location:
Maimonides Medical Center
Schreiber Auditorium, Administration Building, 2nd Floor
4802 10th Avenue, Brooklyn, NY 11219
Virtual symposium: Via Webex (link shared after registration)
CME credit: This activity has been approved for up to 4.5 AMA PRA Category 1 Credits™
Registration: Free, but required to attend
Symposium topics
Symposium topics include the following:
- Advances in the diagnosis and management of peripheral pulmonary nodules
- Comparing contemporary surgical approaches to early-stage lung cancer
- Evaluating the evolving role of radiation therapy across the disease continuum
- Applying biomarker-directed treatment selection in metastatic non-small cell lung cancer (NSCLC)
- The emerging role of bispecific T-cell engager immunotherapy in small cell lung cancer
- Identifying, grading, and managing immune checkpoint inhibitor–related pneumonitis
Learning objectives
The main symposium objective is provider education regarding lung screening eligibility and departmental services available for warranted interventions, including surgery and targeted therapies.
We also aim to provide healthcare professionals with a comprehensive, multidisciplinary perspective on lung cancer care while demonstrating the value of collaboration, early detection, evidence-based treatment, and patient-centered decision-making.
Who should attend
This conference is designed for physicians and advanced practice providers working in the following areas:
- Cardiovascular disease
- Pulmonology and critical care
- Radiology (diagnostic and interventional)
- General and thoracic surgery
- Medical, hematology, and radiation oncology
- Pathology
- Nuclear medicine
- Anesthesiology
- Genetics
- Research and clinical trials
2026 program details
Our 2026 program will be updated as all details are finalized.
7:00–8:00 am: Registration and breakfast
For registration, please visit the table outside Schreiber Auditorium.
For breakfast, please visit Room 2C.
8:00 am–2:00pm: Exhibitors: Amgen, AstraZeneca, AtriCure, Biodesix, Bristol Myers Squibb, Intuitive, Natera
Exhibitors will be set up for the duration of the event in Room 2C.
8:00–8:05 am: Welcome
Patrick Borgen, MD
Head, Maimonides Breast Center, Maimonides Cancer Center
Chair, Department of Surgery, Maimonides Medical Center
8:05–8:10 am: Opening remarks
Odai Sinokrot, MD
Attending Physician, Pulmonary, Critical Care, and Sleep Medicine, Maimonides Medical Center
8:10–8:40 am: Screening the Unscreened: The New York Female Asian Nonsmoker Screening Study (FANSS) and a New Paradigm for Lung Cancer Detection in Asian Never-Smokers
Elaine Shum, MD
Director, Cancer Screening Programs, NYU Langone Health’s Perlmutter Cancer Center
Assistant Professor of Medicine, NYU Grossman School of Medicine
8:40–9:10 am: Advances in Navigational Bronchoscopy as a Diagnostic and Emerging Therapeutic Tool
Vivek Murthy, MD, FCCP
Director, Interventional Pulmonology Fellowship, NYU Langone Health
Director, Lung Cancer Screening Program and Interventional Pulmonology, NYC Health + Hospitals/Bellevue
Assistant Professor of Medicine and Cardiothoracic Surgery, NYU Grossman School of Medicine
9:10–9:40 am: Operating after Chemoimmunotherapy: Robotic Surgery in the Neoadjuvant Immunotherapy Era
Alexandra Renzi, MD
Attending Physician, Division of Thoracic Surgery, Maimonides Medical Center
9:40–9:50 am: Break
9:50–10:20 am: Beyond Surgery: Optimizing Perioperative Therapy in Lung Cancer
Julie Huang, DO
Attending Physician, Division of Hematology-Oncology, Maimonides Medical Center
10:20–10:50 am: Radiation Oncology Update in Lung Cancer Care
David Berlach, MD
Chair, Department of Radiation Oncology, Maimonides Medical Center
Clinical Assistant Professor, SUNY Downstate Medical Center
10:50–11:20 am: Metastatic NSCLC with ALK Fusions: A Case Study. Introducing Precision Oncology for Advanced NSCLC
Yiquing Xu, MD
Attending Physician, Division of Hematology-Oncology, Maimonides Medical Center
11:20–11:30 am: Break
11:30 am–12:00 pm: Tarlatamab (IMDELLTRA): A New Standard of Care for Relapsed Small Cell Lung Cancer
Helen Pozdniakova, MD
PGY6 Fellow, Division of Hematology-Oncology, Maimonides Medical Center
Victoria Reesman, APRN
Oncology Nurse Specialist-K6, Maimonides Medical Center
12:00–12:30 pm: Drug-Induced Pneumonitis in the Cancer Patient: A Pulmonary Approach to Evaluation and Grade-Based Management
Odai Sinokrot, MD
Attending Physician, Pulmonary, Critical Care, and Sleep Medicine, Maimonides Medical Center
12:30–12:35 pm: Patient Perspective on Lung Cancer Care at Maimonides
Lisa Grippo, RN
Manager, Trauma Program, Maimonides Medical Center
12:35–1:05 pm: Panel discussion
Speakers:
Ifeyinwa Asuzu, MD
Chief, Cytopathology, Maimonides Medical Center
Ravikaran Patti, MD
Attending Physician, Pulmonary Critical Care, Maimonides Medical Center
Jared Peralta Rowley, MD, MSc
Attending Physician, Department of Radiation Oncology, Maimonides Medical Center
Clinical Assistant Professor, SUNY Downstate Medical Center
Moderator:
Antony Delliturri, DO
Attending Physician, Division of Thoracic Surgery, Maimonides Medical Center
1:05–2:00 pm: Lunch
Lunch will be served in Room 2C.
Continuing education accreditation and credit designation statement
Maimonides Medical Center is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
Maimonides Medical Center designates this LIVE ACTIVITY for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure statement
The Medical Society of the State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with ineligible companies whose products, devices, or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.
Contact us
For more information, please contact us:
Call: 929-627-0274
Email: LungCancerSymposium@maimo.org
Previous symposium
Lung cancer care at Maimonides
Learn more about lung cancer care and screening at Maimonides Cancer Center.